Physician Profile
Based in Little Rock, AR, Renee Peterkin-Mccalman, M.D. is listed in the NPI registry under rheumatology. Renee is also listed as specializing in internal medicine. Medicare claims data shows Renee provided 4,715 services to 1,675 patients. The services billed most often include injection, denosumab, 1 mg, measurement c-reactive protein for detection of infection or inflammation, and red blood cell sedimentation rate, to detect inflammation, automated. NPI 1083097349 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
9101 KANIS RD STE 200
Little Rock, AR 72205
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
4,715 services · 1,675 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| X-ray of hand, 2 views | Imaging | 73120 |
44 | As often as other peers in Rheumatology |
| Dxa bone density measurement of hip, pelvis, spine | Imaging | 77080 |
41 | Less often than most peers in Rheumatology |
| X-ray of foot, 2 views | Imaging | 73620 |
23 | Less often than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
177 | As often as other peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
171 | As often as other peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
92 | As often as other peers in Rheumatology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
34 | Less often than most peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
1,740 | Less often than most peers in Rheumatology |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Drug given | J3301 |
128 | As often as other peers in Rheumatology |
| Injection, ketorolac tromethamine, per 15 mg | Drug given | J1885 |
38 | Less often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Renee Peterkin-Mccalman is a rheumatologist in Little Rock, AR. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Renee Peterkin-Mccalman is listed at 9101 Kanis Rd Ste 200, Little Rock, AR 72205. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (501) 224-6366. Contact the office directly to confirm availability and scheduling.
NPI registry
Renee Peterkin-Mccalman's National Provider Identifier is 1083097349. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Renee Peterkin-Mccalman attended Other, graduating in 2015. This comes from the CMS National Downloadable File.
CMS public data
Renee Peterkin-Mccalman has 11 years experience. Calculated from a graduation year of 2015, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Renee Peterkin-Mccalman performs imaging including x-ray of hand, 2 views and dxa bone density measurement of hip, pelvis, spine; provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Renee Peterkin-Mccalman. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.